Medical Writing Services
33 places
Worldwide report
Every place
- 99Reports naming them
- 3Markets they lead in
- 33Regions & countries
- 2Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Syneos Health or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Where they show up
99 reportsOur reports that name Syneos Health as a key player, by category and place.
- Healthcare Services · 99
Places 33
- Africa 3
- APAC 3
- Australia 3
- Brazil 3
- Canada 3
- China 3
- Ecuador 3
- Egypt 3
- Europe 3
France 3- Germany 3
- Global 3
Hong Kong 3
India 3
Italy 3
Japan 3
Kenya 3- Latin America 3
Malaysia 3
Mexico 3- Middle East 3
New Zealand 3- North America 3
Philippines 3
Russia 3
Saudi Arabia 3
Singapore 3
South Africa 3
Spain 3
Thailand 3- UAE 3
UK 3
US 3
Syneos Health's markets
3Markets where they are a key player. Each opens the market's statistics for every place we cover.
Healthcare Services3
None of their markets match.
Recent reports naming Syneos Health
Our newest markets with them as a key player. Each covers 2024 history, a 2025 base year and forecasts to 2034.
33 places
Rare Disease Clinical Trial Services
33 places
Worldwide report
Every place
Oncology Clinical Trial Services
33 places
Worldwide report
Every place
Companies they compete with most
Named as key players in the same markets as Syneos Health (number of shared markets).
IQVIA3 shared markets
Parexel3 shared markets
ICON Plc2 shared markets
Medpace2 shared markets
Certara1 shared market
Labcorp1 shared market
Trilogy Writing & Consulting1 shared market
Free public data on Syneos Health
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
Company facts
- Website
- syneoshealth.com
- Home country
- United States
- Stock listing
- NASDAQ: SYNH
- Legal name
- Syneos Health, Inc.
- Type
- Medicines
Clinical trials
2 active studies led by Syneos Health, of 22 in all
Source: ClinicalTrials.gov, Studies with Syneos Health (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Trials over time
Studies Syneos Health leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Syneos Health or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Topics
The topics of the markets Syneos Health is in.
From our blog
Stories on the topics Syneos Health works in.
Brain Cancer Diagnosis: Imaging and New Biomarkers
About 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died…
Read
Bioinformatics: Making Sense of Health Data
Sequencing a human genome fell from about $50 million in 2003 to under $1,500 by late 2015. Bioinformatics…
Read
Dermatology Diagnostics: AI and Skin Health
Skin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
Read